NanoString

OverviewSuggest Edit

NanoString Technologies is a provider of life science tools for translational research and molecular diagnostics. The company offers three platforms: nCounter Analysis System, that allows researchers to profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations; GeoMx Digital Spatial Profiler that enables multiplexed spatial profiling of RNA and protein targets in various sample types; and CosMx Spatial Molecular Imager that enables high-resolution imaging of RNAs or proteins directly from single cells within morphologically intact whole tissue sections.
TypePublic
Founded2003
HQSeattle, WA, US
Websitenanostring.com
Employee Ratings4.1
Overall CultureD-

Latest Updates

Employees (est.) (Dec 2021)766(+33%)
Job Openings42
Revenue (FY, 2021)$145.1 M(+24%)
Share Price (Jul 2022)$12.8
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at NanoString

Brad Gray

Brad Gray

President and Chief Executive Officer
Joseph M. Beechem

Joseph M. Beechem

Chief Scientific Officer & Senior Vice President, Research & Development
Thomas Bailey

Thomas Bailey

Chief Financial Officer
William D. Young

William D. Young

Chairman of the Board
David W. Ghesquiere

David W. Ghesquiere

Senior Vice President, Corporate and Business Development
Kathy Surace-Smith

Kathy Surace-Smith

Senior Vice President, Human Resources and Legal Affairs
Show more

NanoString Office Locations

NanoString has offices in Seattle and Amsterdam
Seattle, WA, US (HQ)
530 Fairview Ave N
Amsterdam, NL
Paasheuvelweg 25
Show all (2)

NanoString Financials and Metrics

NanoString Revenue

NanoString's revenue was reported to be $145.09 m in FY, 2021
USD

Revenue (Q1, 2022)

31.1m

Net income (Q1, 2022)

(39.5m)

EBIT (Q1, 2022)

(37.5m)

Market capitalization (29-Jul-2022)

584.3m

Closing stock price (29-Jul-2022)

12.8

Cash (31-Mar-2022)

98.5m
NanoString's current market capitalization is $584.3 m.
Annual
USDFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

106.7m125.6m117.3m145.1m

Revenue growth, %

(7%)18%(7%)

Cost of goods sold

36.3m44.0m52.4m68.3m

Gross profit

70.4m81.5m64.9m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Revenue

27.7m30.3m30.6m26.6m22.6m31.8m31.6m33.9m37.2m31.1m

Cost of goods sold

8.7m9.6m10.9m11.0m10.7m14.0m15.6m15.5m17.2m14.8m

Gross profit

19.0m20.7m19.7m15.6m11.9m17.9m16.0m18.4m20.0m

Gross profit Margin, %

69%68%64%59%53%56%51%54%54%
Annual
USDFY, 2018FY, 2019FY, 2020FY, 2021

Cash

24.4m29.0m411.8m107.1m

Accounts Receivable

17.3m27.2m31.1m40.1m

Prepaid Expenses

7.3m8.8m4.2m7.1m

Inventories

13.2m19.8m23.0m31.5m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Cash

15.6m24.3m21.2m84.1m33.4m23.4m155.6m168.4m171.5m396.5m160.4m107.2m98.5m

Accounts Receivable

16.3m17.4m18.5m18.1m19.0m19.5m21.2m22.0m25.8m33.2m32.0m35.5m30.4m

Prepaid Expenses

5.8m5.9m7.1m8.6m9.2m10.9m5.4m3.2m4.0m6.9m7.4m9.5m10.1m

Inventories

19.1m17.6m15.0m13.0m16.5m19.0m22.2m26.0m26.2m24.4m28.7m31.1m34.6m
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020FY, 2021

Net Income

(43.6m)(77.4m)(40.7m)(110.1m)(115.3m)

Depreciation and Amortization

3.4m4.1m4.9m5.7m5.9m

Inventories

(8.7m)5.3m(8.5m)(4.9m)(10.5m)

Accounts Payable

(110.0k)4.6m(599.0k)(3.2m)8.7m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Net Income

(18.9m)(23.4m)(34.8m)(19.2m)(39.8m)(56.3m)(21.9m)(41.9m)(64.7m)(38.6m)(65.8m)(87.1m)(27.7m)(54.7m)(86.0m)(39.5m)

Depreciation and Amortization

814.0k1.7m2.5m928.0k2.0m3.0m1.2m2.4m3.6m1.2m2.8m4.3m1.4m2.9m4.3m1.5m

Inventories

(837.0k)(2.5m)(5.9m)817.0k1.6m3.5m(465.0k)(4.4m)(7.2m)(2.7m)(6.6m)(6.8m)(2.2m)(7.0m)(10.3m)(4.1m)

Accounts Payable

(2.1m)(392.0k)(1.7m)716.0k1.1m1.3m(1.9m)(2.6m)(2.0m)(260.0k)(2.8m)(4.3m)943.0k6.0m7.0m3.9m
Show all financial metrics

NanoString Operating Metrics

FY, 2017FY, 2018FY, 2019

Product Platforms

112

Facilities Leased

578

Patent Applications (US)

403627

Patents and Patent Applications

255266290

NanoString Acquisitions / Subsidiaries

Company NameDateDeal Size
NanoString Technologies Asia Pacific Limited
NanoString Technologies (Bejing) Co. Ltd.
NanoString Technologies Europe Limited
NanoString Technologies Germany GmbH
NanoString Technologies International
NanoString Technologies SAS
NanoString Technologies Singapore Pte Limited
NanoString Technologies Spain, S.L.

NanoString Revenue Breakdown

Embed Graph

NanoString revenue breakdown by business segment: 40.8% from Instruments, 42.7% from Consumables, 11.5% from Service and 5.0% from Collaboration

NanoString revenue breakdown by geographic segment: 22.9% from Europe & Middle East, 68.0% from Americas and 9.1% from Asia Pacific

NanoString Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

NanoString Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

NanoString Online and Social Media Presence

Embed Graph

NanoString Company Culture

  • Overall Culture

    D-

    57/100

  • CEO Rating

    C-

    65/100

  • Compensation

    D+

    60/100

  • Diversity

    B

    78/100

Learn more on Comparably

NanoString News and Updates

Worldwide Industry for Spatial Genomics and Transcriptomics to 2030 - Players Include NanoString Technologies, S2 Genomics & Flagship Biosciences Among Others

Dublin, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The "Global Spatial Genomics and Transcriptomics Market: Focus on Product Type, Sample Type, Workflow, Application, End User, Region and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock

SEATTLE, March 19, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price …

NanoString Technologies Announces Commencement of Public Offering of Common Stock

SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an underwritten public offering of 4,500,000 shares of its common stock pursuant to its shelf regi…

NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018

— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance —— Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers —

NanoString Blogs

A new map for our anatomy: the Spatial Organ Atlas

One year for spring break, we found ourselves in Portland, Oregon. For science-y people, a trip to Portland would be... The post A new map for our anatomy: the Spatial Organ Atlas appeared first on NanoString.

Is your Lab Secure?  Exploring the New Cyberbiosecurity World

As someone who is involved in molecular biology research, how often do you think about cybersecurity? Occasionally? Never? Perhaps you... The post Is your Lab Secure?  Exploring the New Cyberbiosecurity World appeared first on NanoString.

GeoMx® DSP Integrated with Sequencing Run Planning for NextSeq 1000/2000

Illumina and NanoString® collaborated further to pair the GeoMx® DSP with NGS readout from Illumina sequencing instruments. This partnership enables... The post GeoMx® DSP Integrated with Sequencing Run Planning for NextSeq 1000/2000 appeared first on NanoString.

Five Key Milestones in the History of Research in Cancer Biology

On a cold snowy day in late November 2016, I sat with my father-in-law at the infusion clinic in the... The post Five Key Milestones in the History of Research in Cancer Biology appeared first on NanoString.

The GeoMx® Digital Spatial Profiler is Aiding Global Infectious Disease Researchers to Reveal How the Immune System Responds to HIV

Imagine a world without HIV The innate immune response is the first line of defense against the pathogen during a... The post The GeoMx® Digital Spatial Profiler is Aiding Global Infectious Disease Researchers to Reveal How the Immune System Responds to HIV appeared first on NanoString.

How do I choose the right spatial biology technology?

What is Spatial Biology? The rapidly evolving field of spatial biology investigates the spatial location and organization of gene expression in... The post How do I choose the right spatial biology technology? appeared first on NanoString.
Show more

NanoString Frequently Asked Questions

  • When was NanoString founded?

    NanoString was founded in 2003.

  • Who are NanoString key executives?

    NanoString's key executives are Brad Gray, Joseph M. Beechem and Thomas Bailey.

  • How many employees does NanoString have?

    NanoString has 766 employees.

  • What is NanoString revenue?

    Latest NanoString annual revenue is $145.1 m.

  • What is NanoString revenue per employee?

    Latest NanoString revenue per employee is $189.4 k.

  • Who are NanoString competitors?

    Competitors of NanoString include Personalis, EKF Diagnostics and Klox Technologies.

  • Where is NanoString headquarters?

    NanoString headquarters is located at 530 Fairview Ave N, Seattle.

  • Where are NanoString offices?

    NanoString has offices in Seattle and Amsterdam.

  • How many offices does NanoString have?

    NanoString has 2 offices.